BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28297578)

  • 1. β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1.
    Feng HB; Wang J; Jiang HR; Mei X; Zhao YY; Chen FR; Qu Y; Sai K; Guo CC; Yang QY; Zhang ZP; Chen ZP
    Stem Cells Transl Med; 2017 Mar; 6(3):830-839. PubMed ID: 28297578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
    Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
    Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrandrine inhibits glioma stem-like cells by repressing β-catenin expression.
    Zhang Y; Wen YL; Ma JW; Ye JC; Wang X; Huang JX; Meng CY; Xu XZ; Wang SX; Zhong XY
    Int J Oncol; 2017 Jan; 50(1):101-110. PubMed ID: 27909720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition.
    Zhang Y; Wang SX; Ma JW; Li HY; Ye JC; Xie SM; Du B; Zhong XY
    J Neurooncol; 2015 Jan; 121(1):41-52. PubMed ID: 25173233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
    Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
    Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells.
    Liu N; Hu G; Wang H; Li Z; Guo Z
    J Cell Mol Med; 2018 Nov; 22(11):5300-5310. PubMed ID: 30133120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma.
    Zeng X; Wang Q; Tan X; Jia L; Li Y; Hu M; Zhang Z; Bai X; Zhu Y; Yang X
    J Nanobiotechnology; 2019 Apr; 17(1):47. PubMed ID: 30935403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iguratimod encapsulated PLGA-NPs improves therapeutic outcome in glioma, glioma stem-like cells and temozolomide resistant glioma cells.
    Younis M; Faming W; Hongyan Z; Mengmeng T; Hang S; Liudi Y
    Nanomedicine; 2019 Nov; 22():102101. PubMed ID: 31654739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells.
    Wang B; Yu SC; Jiang JY; Porter GW; Zhao LT; Wang Z; Tan H; Cui YH; Qian C; Ping YF; Bian XW
    Stem Cell Rev Rep; 2011 Jun; 7(2):458-70. PubMed ID: 20809257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3.
    Wu CX; Xu A; Zhang CC; Olson P; Chen L; Lee TK; Cheung TT; Lo CM; Wang XQ
    Mol Cancer Ther; 2017 Aug; 16(8):1531-1543. PubMed ID: 28522590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
    Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
    Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
    Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N
    PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells.
    Villodre ES; Kipper FC; Silva AO; Lenz G; Lopez PLDC
    Mol Neurobiol; 2018 May; 55(5):4185-4194. PubMed ID: 28612256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
    Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway.
    Hai L; Zhang C; Li T; Zhou X; Liu B; Li S; Zhu M; Lin Y; Yu S; Zhang K; Ren B; Ming H; Huang Y; Chen L; Zhao P; Zhou H; Jiang T; Yang X
    Cell Death Dis; 2018 Feb; 9(2):158. PubMed ID: 29410396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
    Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
    Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
    Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
    J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold quantum dots impair the tumorigenic potential of glioma stem-like cells via β-catenin downregulation in vitro.
    Wahab R; Kaushik N; Khan F; Kaushik NK; Lee SJ; Choi EH; Al-Khedhairy AA
    Int J Nanomedicine; 2019; 14():1131-1148. PubMed ID: 30863050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of IFN-beta on human glioma cell lines with temozolomide resistance.
    Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E
    Int J Oncol; 2009 Jul; 35(1):139-48. PubMed ID: 19513561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine inhibits the proliferation and induces the differentiation of glioma stem-like cells through modulating the Wnt signaling pathway in vitro.
    Guo QH; Yang HJ; Wang SD
    Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2406-15. PubMed ID: 26214776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.